6505--Eszopiclone Tablets - Golden State Medical Supply, Inc.

The Department of Veterans Affairs National Acquisition Center is preparing to solicit proposals under RFP 36E79725R0070 for the supply of Eszopiclone Tablets. This contract will serve multiple federal agencies, including the VA (covering both Consolidated Mail Order Pharmacies and State Veterans Homes), Department of Defense, Bureau of Prisons, Indian Health Service, and the Federal Health Care Center. The contract is set for a base period of one year, with the potential for four additional one-year option periods. Distribution will occur through the existing Pharmaceutical Prime Vendor Programs of both the VA and DOD. Offerors must supply Eszopiclone Tablets in 1mg, 2mg, and 3mg strengths, each in bottles of 30 tablets, with anticipated annual requirements of 39,279, 69,052, and 119,905 bottles, respectively. Stringent labeling and packaging specifications are required: each offeror must use its unique NDC number and proprietary label, and packaging must meet precise safety cap, bottle size, and labeling space requirements. The solicitation will be issued electronically around October 23, 2025, with responses due by November 6, 2025. Prospective bidders are responsible for monitoring sam.gov for updates. Richard Mahario is the primary contract specialist and point of contact for this procurement.